Logo image of COCH

ENVOY MEDICAL INC (COCH) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:COCH - US29415V1098 - Common Stock

0.7975 USD
+0.03 (+3.75%)
Last: 11/25/2025, 12:56:00 PM

COCH Key Statistics, Chart & Performance

Key Statistics
Market Cap22.96M
Revenue(TTM)225.00K
Net Income(TTM)-28.20M
Shares28.79M
Float17.58M
52 Week High2.32
52 Week Low0.64
Yearly Dividend0.12
Dividend YieldN/A
EPS(TTM)-1.41
PEN/A
Fwd PEN/A
Earnings (Next)03-31 2026-03-31/amc
IPO2021-03-02
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


COCH short term performance overview.The bars show the price performance of COCH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40

COCH long term performance overview.The bars show the price performance of COCH in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of COCH is 0.7975 USD. In the past month the price decreased by -5.11%. In the past year, price decreased by -66.29%.

ENVOY MEDICAL INC / COCH Daily stock chart

COCH Latest News, Press Relases and Analysis

15 days ago - By: Zacks Investment Research - Mentions: SINT
19 days ago - By: Zacks Investment Research - Mentions: CLPT
20 days ago - By: Zacks Investment Research - Mentions: AVNS
21 days ago - By: Zacks Investment Research - Mentions: DCTH
a month ago - By: Virtual Investor Conferences; Envoy Medical, Inc.

COCH Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.69 223.07B
ISRG INTUITIVE SURGICAL INC 66.93 206.59B
BSX BOSTON SCIENTIFIC CORP 34.24 149.68B
SYK STRYKER CORP 28.44 143.21B
IDXX IDEXX LABORATORIES INC 60.34 60.88B
BDX BECTON DICKINSON AND CO 13.49 55.76B
EW EDWARDS LIFESCIENCES CORP 33.72 50.29B
RMD RESMED INC 25.83 37.31B
GEHC GE HEALTHCARE TECHNOLOGY 17.62 36.84B
DXCM DEXCOM INC 33.36 24.33B
PODD INSULET CORP 72.03 23.16B
ZBH ZIMMER BIOMET HOLDINGS INC 11.92 19.10B

About COCH

Company Profile

COCH logo image Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 42 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Company Info

ENVOY MEDICAL INC

4875 White Bear Parkway

White Bear Lake MINNESOTA US

Employees: 42

COCH Company Website

COCH Investor Relations

Phone: 16513618000

ENVOY MEDICAL INC / COCH FAQ

What does COCH do?

Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 42 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.


Can you provide the latest stock price for ENVOY MEDICAL INC?

The current stock price of COCH is 0.7975 USD. The price increased by 3.75% in the last trading session.


Does ENVOY MEDICAL INC pay dividends?

COCH does not pay a dividend.


How is the ChartMill rating for ENVOY MEDICAL INC?

COCH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


What is the analyst forecast for COCH stock?

9 analysts have analysed COCH and the average price target is 8.41 USD. This implies a price increase of 955.17% is expected in the next year compared to the current price of 0.7975.


What is ENVOY MEDICAL INC worth?

ENVOY MEDICAL INC (COCH) has a market capitalization of 22.96M USD. This makes COCH a Nano Cap stock.


What is the outstanding short interest for ENVOY MEDICAL INC?

The outstanding short interest for ENVOY MEDICAL INC (COCH) is 3.37% of its float.


COCH Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

COCH Financial Highlights

Over the last trailing twelve months COCH reported a non-GAAP Earnings per Share(EPS) of -1.41. The EPS decreased by -4.44% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -284.89%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%8.11%
Sales Q2Q%-25%
EPS 1Y (TTM)-4.44%
Revenue 1Y (TTM)-28.8%

COCH Forecast & Estimates

9 analysts have analysed COCH and the average price target is 8.41 USD. This implies a price increase of 955.17% is expected in the next year compared to the current price of 0.7975.

For the next year, analysts expect an EPS growth of 13.56% and a revenue growth -17.84% for COCH


Analysts
Analysts82.22
Price Target8.41 (954.55%)
EPS Next Y13.56%
Revenue Next Year-17.84%

COCH Ownership

Ownership
Inst Owners56.67%
Ins Owners49.46%
Short Float %3.37%
Short Ratio0.16